Actualités de Germany
- 2plus
New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines
Darmstadt, Germany (ots/PRNewswire) - MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial findings from the CLOCK-MS vaccine ...
plusEuropean Datawarehouse Submits Application to FCA to be Registered as a UK Securitisation Repository
Frankfurt, Germany (ots/PRNewswire) - European DataWarehouse (EDW) today announced it has submitted its application to become a Securitisation Repository in the UK registered and supervised by the Financial Conduct Authority (FCA). The extensive application describes in detail the sound operational and technical ...
plusNEC Laboratories Europe's Unikraft Doubles Cloud Computing Efficiency with Groundbreaking Technology
Heidelberg, Germany (ots/PRNewswire) - NEC Laboratories Europe recently demonstrated the effectiveness of its Unikraft technology by doubling the data throughput on a NGINX web server while running on Amazon Web Services (AWS). This is compared to the same web server running on a Linux-based image. The result is equivalent to reducing server resource costs by half, as ...
plusEvolution Equity Partners Expands Cybersecurity Focused Investment Platform
New York, Palo Alto, Calif. and Zurich, Germany (ots/PRNewswire) - The firm expands capital base, team and access to best of breed software companies amidst growing investment opportunity Evolution Equity Partners expands cybersecurity investment platform in 2020 as a leading investor in the segment. The firm grows its capital base, AUM, team and partnerships with best ...
plusEuropean DataWarehouse Named in Latest Action Plan For European NPLs
Frankfurt, Germany (ots/PRNewswire) - European DataWarehouse (EDW) today announced it has been put forward by the European Commission (EC) as a solution for a European Non-Performing Loan (NPL) Data Hub. The report was published as part of the EC's Action Plan on NPLs on 16 December 2020. The Action Plan includes a dedicated section on Data Infrastructure which states ...
plusNovaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
Heidelberg, Germany (ots/PRNewswire) - - ESSENCE-2 is the second registration trial to complete the clinical development of CyclASol® as agreed with U.S. Food and Drug Administration (FDA) - Designed to replicate efficacy demonstrated in previous phase 2/3 ESSENCE-1 trial - Topline data expected in 2nd half 2021 ...
plusEuropean Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations
Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial ...
plusMerck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up to EUR 605 million in development ...
plusTHOMAS SABO and Rita Ora inspire with Magic Stars Collection
Lauf An Der Pegnitz, Germany (ots/PRNewswire) - THOMAS SABO is celebrating the most beautiful time of the year with its new Magic Stars Collection, and from 15th October 2020, will be presenting exquisite pieces of jewellery that sparkle like a thousand stars in the night sky. Brand ambassador Rita Ora is once again the face of the campaign and inspires with a festive look. The intricately worked Sterling silver jewellery ...
plusGerresheimer on track for strong second half-year
Dusseldorf, Germany (ots/PRNewswire) - - Third quarter on schedule - Group revenues EUR 349m; 2.1% organic revenue growth in core business - Adjusted EBITDA increases by 4.1% to EUR 75m - Significant improvement in free cash flow to EUR 38m - Strong fourth quarter 2020 expected - Guidance for 2020 confirmed Gerresheimer AG delivered profitable growth in its core business in the third quarter of 2020 and confirmed its ...
plusMerck Announces Out-Licensing Agreement for Phase II-ready Anti-ADAMTS5 Nanobody for Osteoarthritis
Darmstadt, Germany (ots/PRNewswire) - - Merck out-licenses promising clinical-stage program to Novartis - Anti-ADAMTS5 Nanobody® programis Phase II-ready with novel MoA which could protect against cartilage damage and reduce joint pain - Merck receives upfront payment of EUR 50 million with the potential of ...
plusJennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
Rheinbreitbach and Bonn, Germany (ots/PRNewswire) - Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/Denmark, to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares ...
plusiPoint enters strategic partnership with Toyota Tsusho Systems
Reutlingen, Germany (ots/PRNewswire) - Sustainable market presence for iPoint's software in Japan iPoint-systems, a leading provider of software and services for environmental and social product compliance, and sustainability, today announced a new partnership with the well-established Japanese IT trading company Toyota Tsusho Systems (TTS). With this partnership, ...
plusMerck Advances Oncology Portfolio and Pipeline with New and Long-term Data in Multiple Cancers at ESMO 2020
Darmstadt, Germany (ots/PRNewswire) - · New analyses from Phase III JAVELIN Bladder 100 study of BAVENCIO®* assess efficacy across subgroups, patient-reported outcomes and exploratory biomarkers in advanced urothelial cancer · Overall efficacy data, and analyses of brain metastases and HRQoL for tepotinib? from ...
plusNew MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
Darmstadt, Germany (ots/PRNewswire) - In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical ...
plusMerck Announces Positive Phase II Results for Investigational Sonelokinab (M1095) in Patients with Moderate to Severe Chronic Plaque-Type Psoriasis
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Sonelokinab is an investigational IL-17 A/F Nanobody®, which neutralizes both IL-17A and IL-17F - Phase II study was facilitated by Avillion as part of an innovative co-development model Merck, a leading science and technology company, ...
plusMerck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK and US based media - Company to present 54 abstracts across its MS portfolio - MAVENCLAD® (cladribine tablets), Rebif® (interferon beta-1a) and investigational evobrutinib - New long-term data and real-world evidence further characterise efficacy and safety ...
plusHARTING Technology Group has been shaping the future for 75 years
Espelkamp, Germany (ots/PRNewswire) - Innovative products and solutions for Industry 4.0 For 75 years now, the HARTING Technology Group has been driving technological change. The vision formulated in 1996 by the owner family "We want to shape the future with technologies for people" remains the guiding star of our entrepreneurial activities. September 1 marks the 75th anniversary of the founding day of the family company. ...
plusStephan Sieber Awarded EUR 1 Million Future Insight Prize 2020 by Merck
Darmstadt, Germany (ots/PRNewswire) - - Prof. Sieber is developing approaches against multi-resistant pathogens at the Technical University of Munich - Inaugural Johann Anton Merck Award presented to Prof. Caroline Dive, Cancer Research UK, for her liquid biopsy research - Sibel Health awarded the Nature Spinoff Prize Merck, a leading science and technology company, ...
plusIDELVION® Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
Hattersheim, Germany (ots/PRNewswire) - European Medicines Agency Approves 21-Day Dosing Intervals for Adult Haemophilia B Patients Global biotherapeutics leader CSL Behring announced today that the European Medicines Agency (EMA) has approved the new Summary of Product Characteristics, which includes information about new, extended dosing options for IDELVION® ...
plusAnnual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share
Duesseldorf, Germany (ots/PRNewswire) - Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG. "In 2019, we paved the way for profitable growth and achieved a substantial improvement in the Company's culture and dynamic. We are investing and working to grow our innovation pipeline. These efforts continue ...
plusIgNova files patent application on antibody against COVID-19
Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...
plusMerck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS
Darmstadt, Germany (ots/PRNewswire) - - Merck and Twitch collaborate on World MS Day to increase understanding of the impact of multiple sclerosis (MS) - Livestream event with Twitch influencers on May 30 will raise awareness and money for the MS International Federation and help connect people affected by the disease, in line with official World MS Day theme MS ...
plusDERMALOG Identification Systems GmbH
DERMALOG Fever Check at German Baltic Hotel
Usedom and Hamburg, Germany (ots/PRNewswire) - - Picture is available at AP Images ( http://www.apimages.com/ ) - In the course of the Corona pandemic, the hospitality industry has come under increased scrutiny by public authorities. Incidents such as the Covid-19 outbreak in the Austrian town of Ischgl have led to extensive regulations for the safe operation of hotels and restaurants. At the same time, owners are ...
plusBreakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
Darmstadt, Germany (ots/PRNewswire) - - Results from two studies of BAVENCIO® to be featured in ASCO press briefing - Primary efficacy, biomarker and HRQoL analyses for tepotinib?, the first MET inhibitor to have received a regulatory approval for NSCLC with MET gene alterations - Two-year follow-up for first-in-class bifunctional immunotherapy bintrafusp alfa? ...
plusData From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
Darmstadt, Germany and New York (ots/PRNewswire) - - Not intended for US-, Canada- or UK-based media - ASCO Abstract # BAVENCIO® (avelumab): LBA1, 5061; Bintrafusp alfa (bifunctional fusion protein): 9558; Tepotinib (MET kinase inhibitor): 9556, 9575. - Late-breaking presentation of Phase III JAVELIN Bladder 100 data for BAVENCIO® showing overall survival benefit in ...
plusEW Nutrition Launches Industry-leading Webinar Series With Topical Antimicrobial Resistance Twin Sessions
Visbek, Germany (ots/PRNewswire) - Yesterday, German-based company EW Nutrition took a first step toward serving the animal production industry in these challenging times. The in-feed and on-farm solutions company has started a series of topical webinars on challenging issues such as neonatal pig management, poultry ...
plusERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Darmstadt, Germany (ots/PRNewswire) - Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, ...
plusA revolution in laparoscopic training: KARL STORZ and VirtaMed leap beyond VR simulation
plus